News | January 24, 2025
Alivus Life Sciences delivers 12% revenue growth
EBITDA margins expand to 31.3%
EBITDA margins expand to 31.3%
The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and CDMO space
Morepen Laboratories approves hiving off of medical devices business
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
There was no casualty or loss of human life in the incidence
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Glenmark Life Sciences has reported total income of Rs. 515.41 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
